Literature DB >> 30148018

Metastatic Lung Adenocarcinoma Presenting with Hypereosinophilia.

Omar Abughanimeh1, Mohammad Tahboub2, Mouhanna Abu Ghanimeh3.   

Abstract

Lung cancer is one of the most common malignancies in both male and female patients. It is classified into small cell lung cancers and non-small cell lung cancers. Lung adenocarcinoma is a subtype of non-small cell lung cancer and accounts for the highest prevalence of lung cancer. Eosinophils are white blood cells (WBCs) that originate from the granulocytic lineage. Hypereosinophilia is a rare condition characterized by an absolute eosinophil count (AEC) of more than 1500 cells/µL. This is different from eosinophilia, which is defined as an absolute eosinophil count of more than 500 cells/µL. Hypereosinophilia is associated with several conditions, including allergic disorders, helminth infections, rheumatologic disorders, and hematologic malignancies. Paraneoplastic eosinophilia is a rare finding in solid malignancies. Herein, we report the case of a 55-year-old male who presented with shortness of breath and chest pain and whose workup showed metastatic lung adenocarcinoma associated with hypereosinophilia in the absence of a primary bone marrow disorder.

Entities:  

Keywords:  eosinophilia; hypereosinophilia; metastatic lung adenocarcinoma

Year:  2018        PMID: 30148018      PMCID: PMC6107036          DOI: 10.7759/cureus.2866

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

1.  Lung carcinoma associated with excessive eosinophilia.

Authors:  Hazem El-Osta; Peter El-Haddad; Nassim Nabbout
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

Review 2.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma.

Authors:  I Kasuga; S Makino; H Kiyokawa; H Katoh; Y Ebihara; K Ohyashiki
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

4.  Pulmonary carcinoma with eosinophilia. Demonstration of a tumor-derived eosinophilopoietic factor.

Authors:  A Slungaard; J Ascensao; E Zanjani; H S Jacob
Journal:  N Engl J Med       Date:  1983-09-29       Impact factor: 91.245

Review 5.  Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment.

Authors:  Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2005-01       Impact factor: 7.616

6.  Lung cancer with eosinophilia in the peripheral blood and the pleural fluid.

Authors:  S Matsumoto; T Tamai; K Yanagisawa; S Kawamura; S Fujita
Journal:  Intern Med       Date:  1992-04       Impact factor: 1.271

7.  Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.

Authors:  C L Sawyers; D W Golde; S Quan; S D Nimer
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

8.  Large cell carcinoma of the lung associated with marked eosinophilia. A case report.

Authors:  T Kodama; K Takada; T Kameya; Y Shimosato; R Tsuchiya; T Okabe
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

Review 9.  Eosinophilia: a pragmatic approach to diagnosis and treatment.

Authors:  Amy D Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

10.  Rapidly evolving asymptomatic eosinophilia in a patient with lung adenocarcinoma causes cognitive disturbance and respiratory insufficiency: Case report.

Authors:  Cheng-Hsiang Lo; Yee-Min Jen; Wen-Chiuan Tsai; Ping-Ying Chung; Woei-Yau Kao
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

View more
  9 in total

1.  Case Report: Metastatic Dedifferentiated Liposarcoma Presenting as Hypereosinophilia in an Adolescent.

Authors:  Sadhana Balasubramanyam; Joud Hajjar
Journal:  J Immunother Precis Oncol       Date:  2020-10-29

Review 2.  Eosinophils and melanoma: Implications for immunotherapy.

Authors:  India Robinson; Gabriella Santa Lucia; Andraia Li; Nathaniel Oberholtzer; John Plante; Kristen M Quinn; Daniel Reuben; Shikhar Mehrotra; Manuel Valdebran
Journal:  Pigment Cell Melanoma Res       Date:  2022-01-18       Impact factor: 4.159

3.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

4.  Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab.

Authors:  Hisham Wehbe; Maria Kozah; Salwa A Koubaissi
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2021-07-31

5.  Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis.

Authors:  Lindsey Sloan; Rakhi P Naik; Kavita Umrau; Rena Ruiyu Xian; Kristen A Marrone; Khinh Ranh Voong
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

6.  Clopidogrel-induced Eosinophilia with Hypercalcemia.

Authors:  Kazuhiro Yamada; Kazuhisa Asai; Misaki Yanagimoto; Risa Sone; Satsuki Inazu; Ryo Mizutani; Hideaki Kadotani; Tetsuya Watanabe; Yoshihiro Tochino; Tomoya Kawaguchi
Journal:  Intern Med       Date:  2022-02-08       Impact factor: 1.282

Review 7.  Mechanisms and Neuroimaging Patterns of Hypereosinophilia-Related Ischemic Stroke: A Narrative Review through Three Cases.

Authors:  Maria Cristina Cioclu; Francesco Cavallieri; Manuela Napoli; Claudio Moratti; Rosario Pascarella; Franco Valzania; Marialuisa Zedde
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

8.  Leucocytosis and Stroke in a Lung Cancer Patient.

Authors:  Neha Akkad; Yang Jiang; Daniel Shin
Journal:  Eur J Case Rep Intern Med       Date:  2020-08-14

9.  Tumor-associated eosinophilia in a patient with EGFR-positive, MET-amplified lung adenocarcinoma refractory to targeted therapy: a case report and review of literature.

Authors:  Nan Geng; Wenxia Hu; Hui Ge; Shaonan Xie; Cuimin Ding
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.